Table 2.
Transplant information of HSCT patient
| Characteristic | n (%) |
|---|---|
| Primary Disease | |
| Lymphoma | 7 (33.3) |
| Leukemia | 7 (33.3) |
| Non-Malignant Disease | 7 (33.3) |
| Type of Transplant | |
| RIC | 12 (57.1) |
| Myeloablative | 9 (42.9) |
| Stem Cell Source | |
| Peripheral Blood | 20 (95.2) |
| Cord | 1 (4.8) |
| Stem Cell Graft Type (HLA Compatibility) | |
| Unrelated Donor | 17 (81.0) |
| Related Donor | 4 (19.0) |
| Length of Stay [Mean(SD)] | 30.2 (±27.8) |
Note. HSCT, Hematopoietic Stem Cell Transplantation; RIC, Reduced Intensity Conditioning; HLA, Human Leukocyte Antigen.